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Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, United StatesDecreased oxygen delivery to tissues is an important downstream
consequence of diabetic microvascular disease. Although endothelial
dysfunction causing abnormal blood ﬂow regulation is often considered
themajor factor in this regard, impaired oxygen delivery by erythrocytes
may also play a role in both vascular and tissue damage. Erythrocytes
in persons with diabetes with poor glycemic control have impaired
deformability, leading to increased fragility and hemolysis (McMillan
et al. 1978). Beyond anemia as a cause of poor oxygen delivery,
decreased erythrocyte deformability in diabetes may also compromise
capillary perfusion and thus impair delivery of oxygen to the tissues.
The studies of Tu et al. (2015) in this issue of EBioMedicine add another
potential factor to the abnormal red cell function in diabetes: high
glucose concentrations cause erythrocyte vitamin C deﬁciency, which
may then ampliﬁes defects in erythrocyte structure and function due to
diabetes alone.
This work was prompted by the astute “clinical” observation that
mice unable to synthesize their ownvitamin C,when placed on a vitamin
C-deﬁcient diet for 12 weeks, showed hemolysis. This was associated
with increased osmotic fragility and conversion of many cells from
biconcave discs to rounded spherocyte forms. The latter are less deform-
able andmore prone to hemolysis than are normal erythrocytes (Waugh
and Sarelius, 1996). Evaluation by gel electrophoresis of erythrocyte
cytoskeletal proteins showed that vitamin C deﬁciency caused loss of
more than 50% of β-spectrin, without changes in other cytoskeletal
proteins. Both the decrease in β-spectrin and the osmotic fragility were
partially reversed after 10 days of ascorbate repletion. Since β-spectrin
is required for normal cytoskeletal structure and function, it seems likely
that its loss or damage accounted for the observed shape changes and
sensitivity to hemolysis. This brings up the question of how ascorbate
deﬁciency caused loss of β-spectrin. Although this was not investigated
in the studies of Tu et al. (2015), it could relate to the previous observa-
tion that susceptible amino acid residues (e.g., cysteines, histidines,
methionines) in β-spectrin are more readily oxidized than those of
other erythrocyte cytoskeletal proteins, even to the point of undergoing
non-enzymatic cleavage of peptide bonds (Arduini et al. 1989). This
would suggest that the antioxidant function of vitamin C is necessary
to preserve β-spectrin and thus cytoskeletal integrity in erythrocytes.☆ The author declares no conﬂicts of interest.
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common in developed countries, it is well established that persons
with diabetes in poor glycemic control have low plasma and leukocyte
vitamin C levels, measured as the fully reduced form, ascorbate
(Cunningham et al. 1991; Ginter et al. 1978). Thus, it was logical for
Tu et al. (2015) to assess the impact of hyperglycemia and diabetes on
erythrocyte vitamin C. Indeed, they found that the ascorbate content
of erythrocytes from diabetic subjects varied inversely with the degree
of hyperglycemia to which they were exposed. This relationship was
not due to changes in plasma ascorbate levels, but rather to the fact
that erythrocytes from both mice and humans take up vitamin C as
the two-electron oxidized form of the vitamin, dehydroascorbate. This
occurs by facilitated diffusion on GLUT-type glucose transporters
(Vera et al. 1993). High but still physiologic extracellular glucose levels
compete with even very low concentrations of dehydroascorbate for
uptake and this decreases intracellular dehydroascorbate available for
conversion to ascorbate. Most cells take up ascorbate directly on one
of the two isoforms of the Sodium-dependent Vitamin C Transporter,
SVCT. However, mature erythrocytes lack this transporter (May et al.
2007). The ability of glucose to impair dehydroascorbate uptake into
erythrocytes makes them unique in that they may be prone to signiﬁ-
cant intracellular vitamin C deﬁciency in diabetes.
Perhaps most important, erythrocyte ascorbate deﬁciency due to
diabetic hyperglycemia may accentuate or even account for known
abnormalities in diabetic erythrocytes. It was shown over 2 decades
ago that β-spectrin in erythrocytes from both type 1 and type 2
diabetics is oxidized and associated with decreased deformability
(Schwartz et al. 1991). Although β-spectrin was not found to be
decreased in diabetic erythrocytes in that study, quantiﬁcation by nor-
malization to β-actin was not carried out. The ﬁnding in the study by
Tu et al. (2015) that sensitivity to hemolysis was inversely correlated
with erythrocyte ascorbate content and more pronounced in diabetic
subjects with poor glycemic control suggests that deﬁcient intracellular
ascorbate could have played a causative role in the changes in diabetic
erythrocytes. This is supported by the parallel observation that erythro-
cyteβ-spectrin (but notα-spectrin)was also decreased in proportion to
the hemoglobin A1C, a measure of glycemic control.
There are implications from this study by Tu et al. (2015). First the
erythrocyte, because of its unique glucose-sensitive mechanism of
vitamin C uptake, may be more susceptible to intracellular ascorbate
deﬁciency than other cell types in which ascorbate is taken up directly.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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spectrin, which in turn likely accounts for decreased deformability
and susceptibility to hemolysis. Third, the hyperglycemia of diabetes
decreases erythrocyte ascorbate, deﬁciency of which could contribute
to decreased erythrocyte fragility in poorly controlled diabetes.
The work opens up several areas for future studies, such as whether
the loss of β-spectrin due to ascorbate deﬁciency is due to oxidative
damage, whether it contributes to the observed increased osmotic
fragility of erythrocytes deﬁcient in ascorbate, and most important,
whether erythrocyte ascorbate deﬁciency accounts for increased
deformability and lysis seen in diabetes. If so, then this study could
prompt further clinical studies of the impact of vitamin C supplements
on erythrocyte fragility in diabetes.
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